Previous 10 | Next 10 |
BRYAN, Texas, May 12, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming ® Manufacturing System, today announces its financ...
iBio (NYSE:IBIO) said on Monday preclinical data evaluating its cancer drug candidate IBIO-101 showed equal efficacy and potency compared with IL-2 sparing anti-CD25 antibody. The company's therapy, IBIO-101, is produced with its FastPharming and Glycaneering Systems, while IL-2 spa...
NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming ® Manufacturing System, announced today a post...
BRYAN, Texas, May 05, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System ® , announced to...
Data Showing Greater Glycosylation Homogeneity with the FastPharming ® System Compared to Traditional Methods to be Presented at PEGS Conference & Expo BOSTON, May 02, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the ...
3 Tips for Penny Stocks Trading in April Trading penny stocks is not easy. But, with the right information by your side, it can be much easier than previously imagined. Now, understanding how to trade penny stocks , which penny stocks are worth it, and what your investing goals are,...
iBio (NYSE:IBIO), a development-stage biotech with operations in contract development, is trading higher for the third straight session triggering doubts how long the rally will last amid a major bearish signal. However, the Bryan, Texas-based company continues to trade more than 90% lower th...
3 Biotech Penny Stocks to Watch in March 2022 Buying penny stocks be a great investment opportunity, but it’s important to understand the risks before you invest. With so many penny stocks to choose from, it can be difficult to find the best ones to buy. And when it comes to ...
BRYAN, Texas, March 11, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System ® , today anno...
iBio, Inc. (IBIO) Q2 2022 Earnings Conference Call February 14, 2022 16:30 ET Company Participants Stephen Kilmer - Investor Relations Tom Isett - Chairman and Chief Executive Officer Martin Brenner - Chief Scientific Officer Rob Lutz - Chief Financial and Business Officer Conference Call Par...
News, Short Squeeze, Breakout and More Instantly...
– The sale of the facility eliminates $13.2M of secured debt – – Completes iBio’s transition to an AI and precision biologics innovation company - SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or th...
2024-05-28 07:30:05 ET Chardan Capital analyst issues BUY recommendation for IBIO on May 28, 2024 05:34AM ET. IBIO was trading at $2.19 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 1 - Hold recommenda...
Strengthened cash position with investment by healthcare specialist investors Expanding into cardio-metabolic space through AstralBio collaboration BRYAN, Texas and SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company...